I wrote the first version of this article in 2014 based on training I developed in 2006. I have updated and reviewed the content to ensure it remains relevant in 2020.
When testing non sterile products, as well as allowed numbers of microbes, there are certain types of microbes that are specified in the regulations as not allowed and still others that can de deemed to be objectionable.
If you work as a microbiologist where you test total microbial aerobic counts (TMAC), total yeast and mould counts (TMYC) and for specific microbes or conduct investigations into the nature of microbes and what impact they may have on the product and the end user, this presentation will benefit you. I will teach you the the following:
- What makes a specified organism
- What makes an objectionable organism
- How to determine if a microbe is objectionable
- Risk assessment considerations
- The benefits of knowing the differences between specified & objectionable organisms
Continue reading →
What follows will form part of a post tentatively titled “GMP Technical Writing”. The larger post will incorporate aspects of Writing Technical Reports and The Need for Documentation and detail the hierarchy of documents within a Quality Management System, what information goes where and how to conduct business process mapping. I’m tossing up on whether to present this as a series of posts or as some sort of presentation style document (pdf or Powerpoint). Continue reading →
The purpose of an internal audit is to ensure the compliance of the process or processes being audited. That the documented procedure is followed, justified, validated. That the operators carrying out the process are trained and have a strong understanding of the process.
Why do we need to audit?
Continue reading →
My reply to a post on LinkedIn.
Current TGA Inspection trends: This presentation will focus on the common types of deficiencies found by the TGA’s GMP Inspectors as well as some data on the number of inspections performed both locally and overseas and compliance rating outcomes for the inspections performed.
Comment 1 stated “…there are patterns that seem to repeat year after year. Poor QMS, inadequate investigations, lack of training.”
My reply to this was:
“The PIC’S guide to GMP stresses the need for a robust QMS and repeats over and over again the need for documentation, solid investigations and adequate training and retraining. It is a wonder why citations regarding a lack of these keep being given.” Continue reading →
Everything related to the production of drugs is based upon a collection of Pharmacopoeia. These contain both guidelines and regulations and are a great source of information (though at times, some interpretation is needed). Continue reading →